美国血液透析患者早期再入院与后续死亡风险相关
该研究基于美国国家登记数据库285,795例成年医保 primary 血液透析患者,分析2010-2013年首次住院后30天内再入院的时间分布及其与一年内死亡的关系。结果显示23.1%的患者发生30天再入院,其中35.9%发生在出院后第一周;无论再入院时间早晚,再入院均与一年内死亡风险显著升高独立相关。
要点
- 血液透析患者30天再入院率为23.1%,其中超过三分之一发生在出院后第一周。
- 再入院时间越晚(15-30天)死亡风险比越高(HR 2.04),但各时间段均显著升高。
- 透析提供者干预并预防早期再入院的窗口可能有限,但再入院仍提示死亡高风险。
核心结论
- 无论再入院发生在出院后0-7天、8-14天还是15-30天,血液透析患者再入院均与一年内死亡风险显著升高独立相关。
研究设计与样本
- 回顾性队列研究,纳入美国国家登记数据库285,795例成年医保 primary 血液透析患者,这些患者在2010-2013年至少有一次住院(首次索引住院)且存活30天以上。
主要发现
- 23.1%的患者在索引出院后30天内再入院,其中35.9%的再入院发生在出院后第一周内。
- 以无再入院为参照,再入院发生在15-30天的死亡风险比HR为2.04(95%CI 2.00-2.09)。
- 再入院发生在8-14天的HR为1.98(95%CI 1.93-2.04),发生在0-7天的HR为1.76(95%CI 1.71-1.80)。
临床怎么用
- 临床应关注血液透析患者出院后30天内再入院风险,尤其第一周内再入院提示需加强随访与干预。
- 再入院时间早晚均与一年内死亡风险升高相关,可将再入院作为死亡风险分层的重要标志。
局限性
- 研究为观察性设计,无法确定再入院与死亡之间的因果关系。
- 仅纳入医保 primary 的成年血液透析患者,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Dialysis providers in the United States may soon be held accountable for their patients' 30-day hospital readmissions. However, few studies have evaluated the timing of readmissions, which determines the window in which dialysis providers could act to prevent readmission. We therefore examined the timing of readmissions of hemodialysis patients in the United States and its association with mortality among 285,795 prevalent adult Medicare-primary hemodialysis patients from a national registry. Patients had at least one hospitalization in 2010-2013 (first index) and survived for 30 days or more. Readmission timing was defined as 0-7, 8-14, or 15-30 days after the index discharge. Multivariable Cox proportional hazards models were used to estimate the association between readmission timing (referent no readmission) and mortality, censored at one year. Overall, 23.1% of patients had readmissions within 30 days of the index discharge, of which over one-third (35.9%) were within the first week. Regardless of timing, patients with readmissions had a higher risk of death within one year, compared to those with no readmissions, with hazard ratios of 2.04 (95% confidence interval 2.00-2.09) for being readmitted within 15-30 days; 1.98 (1.93-2.04) for being readmitted within 8-14 days; and 1.76 (1.71-1.80) for being readmitted within 0-7 days. Thus, opportunities for dialysis providers to intervene and prevent early readmission may be limited. Regardless of the timing, readmission appears independently associated with a substantially increased risk of mortality in this population.
引用
- Plantinga LC, King L, Patzer RE, et al. Early hospital readmission among hemodialysis patients in the United States is associated with subsequent mortality. Kidney Int. 2017. PMID: 28532710. doi:10.1016/j.kint.2017.03.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。